J&J | JNJ - 부채에 대한이자 비용





부채에 대한이자 비용 변화 날짜
AbbVie USD 645M 69M 2026-03
Abbott USD 299M 231M 2026-06
Amgen USD 95.64B 94.98B 2026-06
AstraZeneca USD 340M 144M 2026-06
Baxter International USD 78M 20M 2026-03
Bayer EUR 675M 87M 2025-12
Becton, Dickinson and Co. USD 132M 17M 2026-06
Biogen USD 72.6M 12.6M 2025-06
Boston Scientific USD 96M 6M 2026-06
Bristol-Myers Squibb USD 407M 4M 2026-06
CONMED USD 7.88M 823K 2026-06
Cooper Companies USD 21.5M 600K 2026-06
Dexcom USD 3.1M 1.1M 2026-03
Edwards Lifesciences USD 30M 5.9M 2026-06
Eli Lilly USD 114.7M 134.3M 2025-09
Gilead Sciences USD 247M 7M 2026-06
GlaxoSmithKline GBP 121M 46M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Insulet USD 11M 3.7M 2026-06
Integra LifeSciences USD 22.99M 529K 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 43M 25M 2026-03
Medtronic USD 186M 10M 2026-06
Merck USD 525M 46M 2026-06
Merit Medical Systems USD 12.12M 5.59M 2026-06
Novartis USD 462M 119M 2026-06
Pfizer USD 667M 4M 2026-06
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 287M 109M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teva Pharmaceutical Industries USD 195M 21M 2026-06
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Zimmer Biomet Holdings USD 22.8B 22.73B 2026-06
Zoetis USD 61M 1000K 2026-06